Practice
Featured experience
Incora emerges from chapter 11
We advised an ad hoc group of secured noteholders in connection with Incora’s chapter 11 proceedings
Venture Global $1.75 billion IPO
We advised Venture Global on its IPO and NYSE listing
Interactive Brokers claims for domestic production activities deductions
We are representing Interactive Brokers
Advice to multiple companies on potential tax refunds under the Varian ruling
We are representing clients in refund claims
Amer Sports $1.2 billion credit facilities and €700 million credit facility
We advised the borrowers on the financing transactions
Export Development Canada $3.5 billion global bond offering
The investment-grade bonds are due 2029
Cigna $4.5 billion senior notes offering
The senior notes are due 2029, 2031, 2034 and 2054
Estée Lauder $650 million senior notes offering
The investment-grade notes are due 2034
Metagenomi $93.75 million IPO
The shares are listed on the Nasdaq Global Market
Tenaya Therapeutics $50 million stock and pre-funded warrants offering
The stock is listed on the Nasdaq Global Select Market
Gilead Sciences $4.3 billion acquisition of CymaBay Therapeutics
We are advising Gilead Sciences on the acquisition
Eli Lilly $6.5 billion notes offering
The investment-grade notes are due 2027, 2029, 2034, 2054 and 2064
Deutsche Bank $1 billion notes offering
The fixed-to-floating-rate eligible liabilities notes are due 2028
Air Products and Chemicals $2.5 billion green notes offering
The investment-grade notes are due 2029, 2031 and 2034